
    
      PROTOCOL OUTLINE:

      Patients are sequentially treated with 2 formulations of ursodeoxycholic acid: unmodified
      ursodiol (Actigall) and buffered, enteric-coated ursodiol (Ursocarb). There is a 24-hour
      washout between each 4-week course of therapy.
    
  